[1] Wang H, Watanabe H, Ogita M, et al. Effect of human beta-defensin-3 on the proliferation of fibroblasts on periodontally involved root surfaces [J]. Peptides, 2011, 32(5)∶888-894 [2] Baker PJ, Evans RT, Roopenian DC. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice [J]. Arch Oral Biol, 1994, 39(12)∶1035-1040 [3] Li CH, Amar S. Morphometric, histomorphometric, and microcomputed tomographic analysis of periodontal inflammatory lesions in a murine model [J]. J Periodontol, 2007, 78(6)∶1120-1128 [4] Jin J, Zhang X, Lu Z, et al. Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease [J]. J Periodontal Res, 2014, 49(4)∶518-526 [5] Abe T, Hajishengallis G. Optimization of the ligature-induced periodontitis model in mice [J]. J Immunol Methods, 2013, 394(1-2)∶49-54 [6] Lei L, Li H, Yan F, et al. Hyperlipidemia impaired innate immune response to periodontal pathogen porphyromonas gingivalis in apolipoprotein E knockout mice [J]. PLoS One, 2013, 8(8)∶e71849 [7] Cavagni J, Wagner TP, Gaio EJ, et al. Obesity may increase the occurrence of spontaneous periodontal disease in Wistar rats [J]. Arch Oral Biol, 2013, 58(8)∶1034-1039 [8] Li Y, Lu Z, Zhang X, et al. Metabolic syndrome exacerbates inflammation and bone loss in periodontitis [J]. J Dent Res, 2015, 94(2)∶362-370 [9] Ivanovski S. Periodontal treatment and systemic conditions [J]. Ann R Australas Coll Dent Surg, 2012, 21∶81-84 [10] Borgnakke WS. Does Treatment of Periodontal Disease Influence Systemic Disease [J]. Dent Clin North Am, 2015, 59(4)∶885-917 [11] Caula AL, Lira-Junior R, Tinoco EM, et al. The effect of periodontal therapy on cardiovascular risk markers: a 6-month randomized clinical trial [J]. J Clin Periodontol, 2014, 41(9)∶875-882 [12] 张正,张莉,郑友丽,等.牙周感染对脑梗死患者APP及IL-6水平的影响[J].口腔医学研究,2016,32(2)∶150-153 [13] Semple F, Webb S, Li HN, et al. Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo [J]. Eur J Immunol, 2010, 40(4)∶1073-1078 [14] Pingel LC, Kohlgraf KG, Hansen CJ, et al. Human beta-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response [J]. Immunol Cell Biol, 2008, 86(8)∶643-649 [15] Smithrithee R, Niyonsaba F, Kiatsurayanon C, et al. Human beta-defensin-3 increases the expression of interleukin-37 through CCR6 in human keratinocytes [J]. J Dermatol Sci, 2015, 77(1)∶46-53 [16] 吕晶露,卞添颖,李丽丽,等.重组人β防御素3对牙龈卟啉单胞菌脂多糖致炎作用的影响[J].口腔医学研究,2015,31(12)∶1179-1183 [17] Funderburg N, Lederman MM, Feng Z, et al. Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2 [J]. Proc Natl Acad Sci USA, 2007, 104(47)∶18631-18635 [18] Harvey LE, Kohlgraf KG, Mehalick LA, et al. Defensin DEFB103 bidirectionally regulates chemokine and cytokine responses to a pro-inflammatory stimulus [J]. Sci Rep, 2013, 3∶1232-1242 |